Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests

An ongoing outbreak of severe respiratory pneumonia associated with the 2019 novel coronavirus has recently emerged in China. Here we report the epidemiological, clinical, laboratory and radiological characteristics of 19 suspect cases. We compared the positive ratio of 2019-nCoV nucleic acid amplif...

Full description

Bibliographic Details
Main Authors: Chunbao Xie, Lingxi Jiang, Guo Huang, Hong Pu, Bo Gong, He Lin, Shi Ma, Xuemei Chen, Bo Long, Guo Si, Hua Yu, Li Jiang, Xingxiang Yang, Yi Shi, Zhenglin Yang
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220301089
Description
Summary:An ongoing outbreak of severe respiratory pneumonia associated with the 2019 novel coronavirus has recently emerged in China. Here we report the epidemiological, clinical, laboratory and radiological characteristics of 19 suspect cases. We compared the positive ratio of 2019-nCoV nucleic acid amplification test results from different samples including oropharyngeal swab, blood, urine and stool with 3 different fluorescent RT-PCR kits. Nine out of the 19 patients had 2019-nCoV infection detected using oropharyngeal swab samples, and the virus nucleic acid was also detected in eight of these nine patients using stool samples. None of positive results was identified in the blood and urine samples. These three different kits got the same result for each sample and the positive ratio of nucleic acid detection for 2019-nCoV was only 47.4% in the suspect patients. Therefore, it is possible that infected patients have been missed by using nucleic acid detection only. It might be better to make a diagnosis combining the computed tomography scans and nucleic acid detection. Keywords: 2019 Novel coronavirus pneumonia, Clinical diagnosis, Nucleic acid amplification test
ISSN:1201-9712